Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Authors
Keywords
-
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 109, Issue -, Pages 108889
Publisher
Elsevier BV
Online
2022-06-07
DOI
10.1016/j.intimp.2022.108889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study
- (2022) WON IL JANG et al. ANTICANCER RESEARCH
- Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH)
- (2022) Vikas Ostwal et al. ONCOLOGIST
- Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer
- (2021) Faye K. Tsogas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan
- (2021) Ryosuke Tateishi et al. JOURNAL OF GASTROENTEROLOGY
- CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
- (2021) Navid Sobhani et al. Cancers
- Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients
- (2021) Dong Lin et al. Cells
- A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition
- (2021) Sameh Saber et al. Pharmaceuticals
- The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial
- (2021) Mahmoud S. Abdallah et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis
- (2021) Mahmoud E. Youssef et al. Frontiers in Pharmacology
- Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
- (2021) Ratna Veeramachaneni et al. Journal for ImmunoTherapy of Cancer
- High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection
- (2021) Shingo Shimada et al. Hepatobiliary Surgery and Nutrition
- The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma
- (2021) Hao Xu et al. Journal of Gastrointestinal Oncology
- ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin
- (2021) Bi Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
- (2021) Amir Mohamed Abdelhamid et al. BIOMEDICINE & PHARMACOTHERAPY
- Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects
- (2021) Raheleh Roudi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
- (2021) Amir Mohamed Abdelhamid et al. LIFE SCIENCES
- Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung
- (2021) Eslam E. Abd El-Fattah et al. TOXICOLOGY
- Targeting CD166+ lung cancer stem cells: Molecular study using murine dendritic cell vaccine
- (2021) N.E. El-Ashmawy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer
- (2021) Lisa Haimerl et al. International Journal of Clinical Pharmacy
- ROS in cancer therapy: the bright side of the moon
- (2020) Bruno Perillo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Tumor-Associated Macrophages: Recent Insights and Therapies
- (2020) Jiawei Zhou et al. Frontiers in Oncology
- The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy
- (2020) Adrián E. Granada et al. MOLECULAR BIOLOGY OF THE CELL
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
- (2020) Poonam Sarode et al. Frontiers in Oncology
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial
- (2020) Shuhong Wang et al. CLINICAL CANCER RESEARCH
- Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)
- (2020) Yeseul Kim et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Efficacy and safety of PD‐1/PD‐L1 inhibitor plus chemotherapy versus chemotherapy alone as first‐line treatment for extensive‐stage small cell lung cancer: A systematic review and meta‐analysis
- (2020) Shuang Zhang et al. Thoracic Cancer
- Immunosuppressive role of Benzo[a]pyrene in induction of lung cancer in mice
- (2020) Mohamed L. Salem et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis
- (2019) Fernanda Vacante et al. International Journal of Endocrinology
- Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study
- (2019) Dina Sabry et al. MOLECULAR BIOLOGY REPORTS
- Neutrophil plasticity in the tumor microenvironment
- (2019) Morgan Giese et al. BLOOD
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- M2 macrophages promote NSCLC metastasis by upregulating CRYAB
- (2019) Zhe Guo et al. Cell Death & Disease
- Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol
- (2019) Jean-Pierre Routy et al. BMJ Open
- Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
- (2019) Heng Sheng Sow et al. Cells
- Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells
- (2019) Gastón Amable et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
- (2019) Jian Chen et al. TRENDS IN MOLECULAR MEDICINE
- Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
- (2019) Sara Verdura et al. OncoImmunology
- Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
- (2019) Chanju Lee et al. Journal for ImmunoTherapy of Cancer
- Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
- (2019) Ji‐Hye Park et al. CANCER SCIENCE
- Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1
- (2019) Jing Xue et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Body Mass Index Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC
- (2019) Sai Yendamuri et al. Journal of Thoracic Oncology
- CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis
- (2019) Linsen Ye et al. Aging-US
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Association of CTLA‐4 , TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma
- (2019) Jia‐jia Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
- (2019) Zuzana Macek Jilkova et al. Cancers
- Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
- (2019) Peiqi Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis
- (2019) Xinyu Zhang et al. PLoS One
- Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway
- (2019) Ruijie Sun et al. Cancer Medicine
- The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo
- (2018) Lisa Menegazzo et al. ACTA DIABETOLOGICA
- Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer
- (2018) Yoshikane Yamauchi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management
- (2018) Mandeep Kumar Singh et al. BIOMEDICINE & PHARMACOTHERAPY
- Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
- (2018) Lifeng Li et al. CANCER RESEARCH
- A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
- (2018) Kristen A. Marrone et al. ONCOLOGIST
- Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
- (2018) Felipe V. Pereira et al. Oncotarget
- Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
- (2018) Jie Ma et al. Journal of Immunology Research
- PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma
- (2018) A. Asgarova et al. OncoImmunology
- Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
- (2018) Guohui Qin et al. OncoImmunology
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
- (2018) Marilena Petrera et al. BMC CANCER
- Epidemiology and Management of Hepatocellular Carcinoma
- (2018) Laura Kulik et al. GASTROENTEROLOGY
- Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
- (2018) Takenori Uehara et al. INTERNATIONAL IMMUNOLOGY
- Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish
- (2018) Sofia de Oliveira et al. JOURNAL OF HEPATOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
- (2017) Chi-Fu Chiang et al. Oncotarget
- Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2017) Hae Il Jung et al. Cancer Research and Treatment
- Attenuation of CD4 + CD25 + Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
- (2017) Yuki Kunisada et al. EBioMedicine
- TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy
- (2017) Marco Arrese et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy
- (2016) Ting Yue et al. BMC CANCER
- Hepatocellular Carcinoma Cells Induce Regulatory T Cells and Lead to Poor Prognosis via Production of Transforming Growth Factor-β1
- (2016) Yi Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor
- (2016) Nahla E. El-Ashmawy et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
- (2016) Julien Calderaro et al. HEPATOLOGY
- Effect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant
- (2016) Nahla E. El-Ashmawy et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
- (2016) Mamatha Bhat et al. Oncotarget
- Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
- (2016) Jian-Fei Tu et al. Scientific Reports
- Metformin is a novel suppressor for transforming growth factor (TGF)-β1
- (2016) Han Xiao et al. Scientific Reports
- Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation
- (2015) Monika Cahova et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect of hyperglycemia on hepatocellular carcinoma development in diabetes
- (2015) Yasuhiro Niwa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
- (2015) Yinan Shen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Tumor-associated macrophages in cancers
- (2015) W. Hu et al. Clinical & Translational Oncology
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
- (2015) Mark A. Feitelson et al. SEMINARS IN CANCER BIOLOGY
- Macrophages and cancer: from mechanisms to therapeutic implications
- (2015) Renato Ostuni et al. TRENDS IN IMMUNOLOGY
- Associations Of Metformin Use With Mortality And Disease Progression After Curative Hepatic Resection In Hepatocellular Carcinoma With Type 2 Diabetes Mellitus: A Nationwide Population-Based Study
- (2015) Y Kim et al. VALUE IN HEALTH
- Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
- (2014) Wei-Kai Xiao et al. BMC CANCER
- Paradoxic effects of metformin on endothelial cells and angiogenesis
- (2014) Katiuscia Dallaglio et al. CARCINOGENESIS
- Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients
- (2014) Fenge Li et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Metformin Inhibits Hepatocellular Carcinoma in a Cirrhosis Model
- (2014) D.K. DePeralta et al. JOURNAL OF SURGICAL RESEARCH
- Macrophages associated with tumors as potential targets and therapeutic intermediates
- (2014) Serguei Vinogradov et al. Nanomedicine
- Cucurbitacin B Regulates Immature Myeloid Cell Differentiation and Enhances Antitumor Immunity in Patients with Lung Cancer
- (2012) Ping Lu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα
- (2012) Pratima Sinha et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid suppressor cells and immune modulation in lung cancer
- (2012) Minu K Srivastava et al. Immunotherapy
- Angiogenesis in cancer
- (2011) G. W. Prager et al. Hamostaseologie
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma
- (2010) Chia-Hui Lo et al. JOURNAL OF GENE MEDICINE
- TGF-² Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer
- (2010) Hyo-Sung Jeon et al. Journal of Thoracic Oncology
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started